Summary

Breast Implants Market Summary

The global breast implants market size was estimated at USD 2.66 billion in 2024 and is projected to reach USD 5.16 billion by 2033, growing at a CAGR of 7.7% from 2025 to 2033. Market growth is attributed to the rising demand for aesthetic enhancement procedures, technological advancements in implant materials, and increased awareness about body contouring solutions.

Growing social acceptance of cosmetic surgeries, coupled with the influence of media and celebrity culture, has encouraged more women to opt for breast augmentation. In addition, the availability of minimally invasive techniques and improved implant safety profiles has significantly reduced the hesitation around undergoing such procedures. The latest innovations in breast implant technology are significantly driving market growth by offering improved aesthetic outcomes and enhanced safety. Advanced implants in 2025 feature highly cohesive silicone gels that provide a more natural shape, better feel, and increased durability, reducing the risk of rupture and the likelihood of revision surgeries. Newer designs also incorporate thinner, customizable shells that conform more naturally to the body, resulting in better mobility and a more lifelike appearance. These improvements enhance patient satisfaction and broaden the appeal of breast augmentation procedures.

Global Breast Implants Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast implants market report based on product, shape, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Silicone Breast Implants
• Saline Breast Implants
• Shape Outlook (Revenue, USD Million, 2021 - 2033)
• Round
• Anatomical
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Reconstructive Surgery
• Cosmetic Surgery
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Cosmetology Clinics
• Ambulatory Surgical Centers
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o China
o India
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Purchased database.
1.5. GVR’s internal database
1.6. Secondary sources
1.7. Third Party Perspective
1.8. Primary research
1.9. Details of primary research
1.10. Information or Data Analysis
1.11. Data analysis models
1.12. Market Formulation & Validation
1.13. Model Details
1.14. Commodity flow analysis (Model 1)
1.15. Approach 1: Commodity flow approach
1.16. Volume price analysis (Model 2)
1.17. Approach 2: Volume price analysis
1.18. List of Secondary Sources
1.19. List of Primary Sources
1.20. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Breast Implants Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing number of breast augmentation procedures
3.2.1.2. Rising incidence of breast cancer
3.2.1.3. Introduction of technologically advanced products
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of implant procedure
3.2.2.2. Post-surgical complications
3.2.3. Market Opportunities Analysis
3.2.3.1. Rising demand for cosmetic procedures
3.2.4. Market Challenges Analysis
3.2.4.1. Risks of complications
3.3. Breast Implants Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. Breast Implants Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Breast Implants Market: Product Movement Analysis & Market Share, 2024 & 2033
4.3. Silicone Breast Implants
4.3.1. Silicone Breast Implants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Saline Breast Implants
4.4.1. Saline Breast Implants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Breast Implants Market: Shape Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Breast Implants Market: Shape Movement Analysis & Market Share, 2024 & 2033
5.2.1. Round
5.2.1.1. Round Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.2.2. Anatomical
5.2.2.1. Anatomical Market Estimates and Forecasts 2018 to 2030, (USD Million)
Chapter 6. Breast Implants Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Breast Implants Market: Application Movement Analysis & Market Share, 2024 & 2033
6.3. Cosmetic Surgery
6.3.1. Cosmetic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Reconstructive Surgery
6.4.1. Reconstructive Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Breast Implants Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Breast Implants Market: End Use Movement Analysis & Market Share, 2024 & 2033
7.3. Hospitals
7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Ambulatory Surgery Centers
7.4.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Cosmetology Clinics
7.5.1. Cosmetology Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Breast Implants Market: Regional Estimates & Trend Analysis by Product, Shape, Application, End Use
8.1. Regional Outlook
8.2. Breast Implants Market: Regional Movement Analysis & Market Share, 2024 & 2033
8.3. North America
8.3.1. North America Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.2. U.S.
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Scenario
8.3.2.4. Reimbursement Scenario
8.3.2.5. U.S. Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Scenario
8.3.3.4. Reimbursement Scenario
8.3.3.5. Canada Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.4. Mexico
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Scenario
8.3.4.4. Reimbursement Scenario
8.3.4.5. Mexico Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4. Europe
8.4.1. Europe Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.2. UK
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Scenario
8.4.2.4. Reimbursement Scenario
8.4.2.5. UK Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.3. Germany
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Scenario
8.4.3.4. Reimbursement Scenario
8.4.3.5. Germany Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.4. France
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Scenario
8.4.4.4. Reimbursement Scenario
8.4.4.5. France Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.5. Italy
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Scenario
8.4.5.4. Reimbursement Scenario
8.4.5.5. Italy Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.6. Spain
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Scenario
8.4.6.4. Reimbursement Scenario
8.4.6.5. Spain Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.7. Denmark
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Scenario
8.4.7.4. Reimbursement Scenario
8.4.7.5. Denmark Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.8. Sweden
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Scenario
8.4.8.4. Reimbursement Scenario
8.4.8.5. Sweden Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Competitive Scenario
8.4.9.3. Regulatory Scenario
8.4.9.4. Reimbursement Scenario
8.4.9.5. Norway Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Asia Pacific
8.5.1. Asia Pacific Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.2. Japan
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Scenario
8.5.2.4. Reimbursement Scenario
8.5.2.5. Japan Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.3. China
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Scenario
8.5.3.4. Reimbursement Scenario
8.5.3.5. China Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Scenario
8.5.4.4. Reimbursement Scenario
8.5.4.5. India Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.5. South Korea
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Scenario
8.5.5.4. Reimbursement Scenario
8.5.5.5. South Korea Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.6. Australia
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Scenario
8.5.6.4. Reimbursement Scenario
8.5.6.5. Australia Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.7. Thailand
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Scenario
8.5.7.4. Reimbursement Scenario
8.5.7.5. Thailand Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Latin America
8.6.1. Latin America Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.2. Brazil
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Scenario
8.6.2.4. Reimbursement Scenario
8.6.2.5. Brazil Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.3. Argentina
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Scenario
8.6.3.4. Reimbursement Scenario
8.6.3.5. Argentina Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. Middle East & Africa
8.7.1. Middle East & Africa Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.2. South Africa
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Scenario
8.7.2.4. Reimbursement Scenario
8.7.2.5. South Africa Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.3. Saudi Arabia
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Scenario
8.7.3.4. Reimbursement Scenario
8.7.3.5. Saudi Arabia Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.4. UAE
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Scenario
8.7.4.4. Reimbursement Scenario
8.7.4.5. UAE Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Scenario
8.7.5.4. Reimbursement Scenario
8.7.5.5. Kuwait Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Key Company Profiles
9.2.1. ALLERGAN (AbbVie)
9.2.1.1. Company Overview
9.2.1.2. Financial Performance
9.2.1.3. Product Benchmarking
9.2.1.4. Strategic Initiatives
9.2.2. GC Aesthetics
9.2.2.1. Company Overview
9.2.2.2. Financial Performance
9.2.2.3. Product Benchmarking
9.2.2.4. Strategic Initiatives
9.2.3. SEBBIN
9.2.3.1. Company Overview
9.2.3.2. Financial Performance
9.2.3.3. Product Benchmarking
9.2.3.4. Strategic Initiatives
9.2.4. Mentor Worldwide LLC (Johnson & Johnson)
9.2.4.1. Company Overview
9.2.4.2. Financial Performance
9.2.4.3. Product Benchmarking
9.2.4.4. Strategic Initiatives
9.2.5. Sientra Inc. (Tiger Aesthetics Medical, LLC)
9.2.5.1. Company Overview
9.2.5.2. Financial Performance
9.2.5.3. Product Benchmarking
9.2.5.4. Strategic Initiatives
9.2.6. POLYTECH Health & Aesthetics GmbH
9.2.6.1. Company Overview
9.2.6.2. Financial Performance
9.2.6.3. Product Benchmarking
9.2.6.4. Strategic Initiatives
9.2.7. Establishment Labs S.A.
9.2.7.1. Company Overview
9.2.7.2. Financial Performance
9.2.7.3. Product Benchmarking
9.2.7.4. Strategic Initiatives
9.2.8. Shanghai Kangning Medical Supplies Ltd.
9.2.8.1. Company Overview
9.2.8.2. Financial Performance
9.2.8.3. Product Benchmarking
9.2.8.4. Strategic Initiatives
9.2.9. Guangzhou Wanhe Plastic Materials Co., Ltd.
9.2.9.1. Company Overview
9.2.9.2. Financial Performance
9.2.9.3. Product Benchmarking
9.2.9.4. Strategic Initiatives
9.2.10. HansBioMed
9.2.10.1. Company Overview
9.2.10.2. Financial Performance
9.2.10.3. Product Benchmarking
9.2.10.4. Strategic Initiatives
9.2.11. Bimini Health Tech.
9.2.11.1. Company Overview
9.2.11.2. Financial Performance
9.2.11.3. Product Benchmarking
9.2.11.4. Strategic Initiatives
9.3. Heat Map Analysis/ Company Market Position Analysis
9.4. Estimated Company Market Share Analysis, 2024